FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010396312> ?p ?o ?g. }

• W2010396312 endingPage "670" @default.
• W2010396312 startingPage "663" @default.
• W2010396312 abstract "The therapeutic results of systemic administration of pralidoxime (2-PAM) in the treatment of poisoning with organophosphate-type cholinesterase inhibitors are disappointing. It has been hypothesized that this is due to poor entry of 2-PAM into the brain. To test if survival rates can be improved by direct administration of 2-PAM into the cerebrospinal fluid (CSF), the effect of intrathecal 2-PAM injections upon mortality after paraoxon intoxication was examined. Eight groups of rats (n=30 each) were examined, all of which received paraoxon (1 micromol=272 microg, 3 micromol=816 microg, or 5 micromol=1.36 mg) intraperitoneally (i.p.). One group received no further treatment; the other groups were given 50 micromol (=8.63 mg) 2-PAM i.p., 5 micromol (=863 microg) 2-PAM intrathecally and pentobarbital/lidocaine in various combinations. Results were compared with the no treatment group and the control groups that did not receive any paraoxon injections, but were given intrathecal injections of saline or 2-PAM. The relative risk of death was estimated by Cox survival analysis. Mortality was lowest after treatment with a combination of both i.p. and intrathecal 2-PAM plus pentobarbital, and with 2-PAM i.p. alone plus pentobarbital. Both treatments were significantly better than 2-PAM i.p. alone (p<or=0.0001). Mortality of intrathecal 2-PAM plus either pentobarbital or lidocaine was in the same order of magnitude as 2-PAM i.p. without pentobarbital/lidocaine, which was significantly (p<or=0.05) lower than that of the no treatment group and of the groups that had only been given pentobarbital or lidocaine. Our results indicate that i.p. injections of 2-PAM insufficiently protect the CNS against the effect of paraoxon. Supplementary injection of pentobarbital, presumably by its anticonvulsive action, has a superior efficacy compared to 2-PAM i.p. alone, irrespective of additional intrathecal 2-PAM administration." @default.
• W2010396312 created "2016-06-24" @default.
• W2010396312 creator A5000925128 @default.
• W2010396312 creator A5030518757 @default.
• W2010396312 creator A5031671463 @default.
• W2010396312 creator A5056988791 @default.
• W2010396312 creator A5057664335 @default.
• W2010396312 creator A5072053188 @default.
• W2010396312 date "2008-07-01" @default.
• W2010396312 modified "2023-10-18" @default.
• W2010396312 title "Effect of intrathecal pralidoxime administration upon survival of rats exposed to the organophosphate paraoxon" @default.
• W2010396312 cites W1541490300 @default.
• W2010396312 cites W1589964883 @default.
• W2010396312 cites W1707439038 @default.
• W2010396312 cites W182828160 @default.
• W2010396312 cites W1977295617 @default.
• W2010396312 cites W1978430351 @default.
• W2010396312 cites W1980375260 @default.
• W2010396312 cites W1984790689 @default.
• W2010396312 cites W1987598842 @default.
• W2010396312 cites W2005560581 @default.
• W2010396312 cites W2013643015 @default.
• W2010396312 cites W2014579729 @default.
• W2010396312 cites W2014699632 @default.
• W2010396312 cites W2025094509 @default.
• W2010396312 cites W2030861170 @default.
• W2010396312 cites W2036521048 @default.
• W2010396312 cites W2038197916 @default.
• W2010396312 cites W2044282697 @default.
• W2010396312 cites W2056821940 @default.
• W2010396312 cites W2058203830 @default.
• W2010396312 cites W2058842443 @default.
• W2010396312 cites W2059902328 @default.
• W2010396312 cites W2060883036 @default.
• W2010396312 cites W2061502689 @default.
• W2010396312 cites W2062352381 @default.
• W2010396312 cites W2062506940 @default.
• W2010396312 cites W2062923618 @default.
• W2010396312 cites W2062954161 @default.
• W2010396312 cites W2072941576 @default.
• W2010396312 cites W2072988210 @default.
• W2010396312 cites W2073038133 @default.
• W2010396312 cites W2084976225 @default.
• W2010396312 cites W2085924698 @default.
• W2010396312 cites W2087043021 @default.
• W2010396312 cites W2092514612 @default.
• W2010396312 cites W2093336737 @default.
• W2010396312 cites W2095770088 @default.
• W2010396312 cites W2102823681 @default.
• W2010396312 cites W2114102865 @default.
• W2010396312 cites W2138702835 @default.
• W2010396312 cites W2577459782 @default.
• W2010396312 cites W4235217257 @default.
• W2010396312 doi "https://doi.org/10.1016/j.neuro.2008.03.006" @default.
• W2010396312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18457881" @default.
• W2010396312 hasPublicationYear "2008" @default.
• W2010396312 type Work @default.
• W2010396312 sameAs 2010396312 @default.
• W2010396312 citedByCount "5" @default.
• W2010396312 countsByYear W20103963122012 @default.
• W2010396312 countsByYear W20103963122013 @default.
• W2010396312 crossrefType "journal-article" @default.
• W2010396312 hasAuthorship W2010396312A5000925128 @default.
• W2010396312 hasAuthorship W2010396312A5030518757 @default.
• W2010396312 hasAuthorship W2010396312A5031671463 @default.
• W2010396312 hasAuthorship W2010396312A5056988791 @default.
• W2010396312 hasAuthorship W2010396312A5057664335 @default.
• W2010396312 hasAuthorship W2010396312A5072053188 @default.
• W2010396312 hasConcept C126322002 @default.
• W2010396312 hasConcept C157820659 @default.
• W2010396312 hasConcept C161176658 @default.
• W2010396312 hasConcept C181199279 @default.
• W2010396312 hasConcept C185592680 @default.
• W2010396312 hasConcept C2776327929 @default.
• W2010396312 hasConcept C2776588719 @default.
• W2010396312 hasConcept C2776755955 @default.
• W2010396312 hasConcept C2777207434 @default.
• W2010396312 hasConcept C2777397205 @default.
• W2010396312 hasConcept C2778736120 @default.
• W2010396312 hasConcept C2778816929 @default.
• W2010396312 hasConcept C2780149897 @default.
• W2010396312 hasConcept C29730261 @default.
• W2010396312 hasConcept C42219234 @default.
• W2010396312 hasConcept C55493867 @default.
• W2010396312 hasConcept C6557445 @default.
• W2010396312 hasConcept C71924100 @default.
• W2010396312 hasConcept C86803240 @default.
• W2010396312 hasConcept C98274493 @default.
• W2010396312 hasConceptScore W2010396312C126322002 @default.
• W2010396312 hasConceptScore W2010396312C157820659 @default.
• W2010396312 hasConceptScore W2010396312C161176658 @default.
• W2010396312 hasConceptScore W2010396312C181199279 @default.
• W2010396312 hasConceptScore W2010396312C185592680 @default.
• W2010396312 hasConceptScore W2010396312C2776327929 @default.
• W2010396312 hasConceptScore W2010396312C2776588719 @default.
• W2010396312 hasConceptScore W2010396312C2776755955 @default.
• W2010396312 hasConceptScore W2010396312C2777207434 @default.
• W2010396312 hasConceptScore W2010396312C2777397205 @default.

• next